Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First or Second Line Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00696072
What this trial is testing

Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-menopausal Breast Cancer That is Unresectable, Locally Recurrent or Metastatic

Who this might be right for
Metastatic Breast Cancer
Bristol-Myers Squibb 120
Large-scale testing (Phase 3)Study completedNCT00806819
What this trial is testing

Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 718
Large-scale testing (Phase 3)Study completedNCT00474786
What this trial is testing

Temsirolimus Versus Sorafenib As Second-Line Therapy In Patients With Advanced RCC Who Have Failed First-Line Sunitinib

Who this might be right for
Renal Cell Carcinoma
Pfizer 512
Testing effectiveness (Phase 2)WithdrawnNCT00571740
What this trial is testing

Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal Cancer

Who this might be right for
Colorectal Cancer
Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)Study completedNCT00853372
What this trial is testing

AMG 386 Phase 2 Open-Label Renal Cell Carcinoma (RCC) Study 1st Line or After Cytokine Failure in Combination With Sunitinib

Who this might be right for
Advanced Renal Cell Carcinoma
Amgen 85
Testing effectiveness (Phase 2)UnknownNCT00022243
What this trial is testing

T138067 in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer That Has Not Responded to Previous Chemotherapy

Who this might be right for
Lung Cancer
Tularik
Not applicableStudy completedNCT00486252
What this trial is testing

Non Interventional Study in Patients With Open Angle Glaucoma and/or Ocular Hypertension Treated With XALATAN®

Who this might be right for
Glaucoma,Open-AngleOcular Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 996
Large-scale testing (Phase 3)Ended earlyNCT00499369
What this trial is testing

Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IVA Colon Cancer+3 more
National Cancer Institute (NCI) 72
Large-scale testing (Phase 3)Study completedNCT01183780
What this trial is testing

A Study in Second Line Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Eli Lilly and Company 1,072
Testing effectiveness (Phase 2)Study completedNCT00454779
What this trial is testing

PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response

Who this might be right for
Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck
Amgen 113
Testing effectiveness (Phase 2)Study completedNCT01442649
What this trial is testing

Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab

Who this might be right for
Colorectal Cancer
UNICANCER 133
Testing effectiveness (Phase 2)UnknownNCT04555304
What this trial is testing

Phase 2 Study of KH903 in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma As Second-Line Therapy

Who this might be right for
Gastric CancerGastroesophageal Cancer
Chengdu Kanghong Biotech Co., Ltd. 81
Testing effectiveness (Phase 2)UnknownNCT01577784
What this trial is testing

Pazopanib in Second-line Therapy in Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Associació per a la Recerca Oncologica, Spain 27
Testing effectiveness (Phase 2)Study completedNCT00085371
What this trial is testing

Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+2 more
National Cancer Institute (NCI) 116
Post-approval studies (Phase 4)Study completedNCT01129336
What this trial is testing

Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients

Who this might be right for
First or Second Line HER2-negative Breast CancerMetastatic Disease Without Bone Metastasis
Novartis Pharmaceuticals 44
Large-scale testing (Phase 3)Ended earlyNCT02766140
What this trial is testing

SHR1020 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Squamous Non Small Cell Lung Cancer

Who this might be right for
Non Squamous Non Small Cell Lung
Jiangsu HengRui Medicine Co., Ltd. 12
Testing effectiveness (Phase 2)Ended earlyNCT00766246
What this trial is testing

Phase II Avastin Trial for Stage IIIB/IV NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage IIIBNon-small Cell Lung Cancer Stage IV
Pharmatech 125
Early research (Phase 1)Study completedNCT00633529
What this trial is testing

Safety of Adding IMO-2055 to Erlotinib + Bevacizumab in 2nd Line Treatment for Patients With NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
EMD Serono 36
Testing effectiveness (Phase 2)Study completedNCT00778102
What this trial is testing

Avastin (Bevacizumab) in Combination With mFOLFOX-6 or FOLFOXIRI in Patients With Metastatic Colorectal Cancer.

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 80
Large-scale testing (Phase 3)Study completedNCT00349219
What this trial is testing

TORCH: A Study of Tarceva or Chemotherapy for the Treatment of Advanced Non Small Cell Lung Cancer

Who this might be right for
Advanced Non-Small Cell Lung Cancer
National Cancer Institute, Naples 760
Next Page